Using tumor genetic tests to guide treatment choices
Part of Cancer clinical trials.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread (metastatic) and cannot be cured, and it has grown despite at least one prior treatment (or there is no standard first treatment that improves survival).
- Your doctor can measure at least one tumor spot on scans (measurable disease).
- Your general strength/function is good (ECOG 0 or 1, meaning you’re able to do most daily activities).
- You can provide tumor tissue for testing by either a biopsy/surgery for routine care or stored tissue from a past biopsy that has enough material.
- If you could become pregnant, you must have a negative pregnancy test and use contraception during the study and for at least 1 month after stopping. If you’re male, you must use barrier contraception during the study and for at least 1 month after stopping.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring treatment to your tumor's specific genetic makeup can help when standard treatments are no longer working. It may give you access to therapies that are more likely to work for your cancer.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This trial looks at your tumor’s genetic information from stored tissue to help match you to early-phase treatment options. It may help doctors find a therapy that fits your tumor, especially when standard options have limited benefit.
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
Hear when a new Unspecified Adult Solid Tumor, Protocol Specific trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.